How Has The Non-Opioid Pain Patch Market Size Evolved Historically?
The non-opioid pain patch market has seen considerable growth due to a variety of factors.
•In past years, the non-opioid pain patch market has seen robust expansion. Its size is predicted to catapult from $3.48 billion in 2024 to $3.66 billion in 2025, marking a compound annual growth rate (CAGR) of 5.1%.
The market's historical growth can be credited to a surge in chronic pain instances, patients favoring non-intrusive treatment methods, enhanced compositions and ingredients, an upswing in sports-related injuries, and worries about opioid dependence.
What Will Be The Non-Opioid Pain Patch Market Size In The Future?
The non-opioid pain patch market is expected to maintain its strong growth trajectory in upcoming years.
• The market for non-opioid pain patches is predicted to experience a robust expansion in the coming years, reaching a valuation of $4.5 billion by 2029, with a compound annual growth rate of 5.3%.
The expected surge during the forecasting timeframe can be ascribed to factors such as an increased emphasis on research and development, escalating healthcare spending, favourable rules and regulations, heightened consumer knowledge and education, as well as a growing elderly demographic. Noteworthy trends during this period are expected to be the development of wireless and intelligent patch technologies, incorporation of natural ingredients, compatibility with wearable tech, biodegradable and environmentally-friendly patches, and a concentration on prolonged effects.
What Are The Key Drivers Fueling Growth In The Non-Opioid Pain Patch Market?
The increasing occurrence of chronic pain, a severe pain that persists for a prolonged period or coincides with a different medical condition, is expected to drive the expansion of the non-opioid pain patch market. These patches are utilized to alleviate mild to moderate pain, combat headaches, muscle aches, arthritis, backaches, and other pain types. To illustrate, Eurostat, the government agency based in Luxembourg, noted in November 2023 that in the preceding year, over a third or 36.1% of individuals in the EU reported experiencing a long-term (chronic) health condition. Consequently, the heightened prevalence of chronic pain is fueling the growth of the non-opioid pain patch market.
What Are The Principal Market Segments In The Global Non-Opioid Pain Patch Industry?
The non-opioid pain patch market covered in this report is segmented –
1) By Patch: Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ketoprofen Patches, Other Patches
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
3) By Indication: Musculoskeletal Pain, Neuropathic Pain
Subsegments:
1) By Lidocaine Patches: 5% Lidocaine Patch, Other Concentrations
2) By Diclofenac Patches: 1.3% Diclofenac Patch, Other Concentrations
3) By Capsaicin Patches: 8% Capsaicin Patch, Other Concentrations
4) By Ketoprofen Patches: 5% Ketoprofen Patch, Other Concentrations
5) By Other Patches: Combination Patches, Herbal Extract Patches, Other Non-Opioid Patches
Pre-Book The Non-Opioid Pain Patch Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Non-Opioid Pain Patch Sector?
Product innovation is becoming a significant trend in the non-opioid pain patch market, as key players seek to enhance their market positions through innovative product offerings. For example, in June 2022, The Mentholatum Company Inc., a health product manufacturer from the UK, rolled out a drug-free pain patch known as the Deep Relief Actiflex Patch. This cooling hydrogel patch, which contains water, delivers quick cooling and soothing relief as the water evaporates on the skin. This non-medicated pain patch is effective in treating muscular and joint aches and pains.
Who Are the Key Players in the Non-Opioid Pain Patch Market?
Major companies operating in the non-opioid pain patch market include:
• Hisamitsu Pharmaceutical Co.
• Inc.
• Teikoku Pharma USA
• Inc.
• Purdue Pharma L.P.
• Noven Pharmaceuticals
• Inc.
• Johnson & Johnson Services
• Inc.
• Pfizer Inc.
• Grünenthal GmbH
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Endo Pharmaceuticals Inc.
• Medtronic plc
• Abbott Laboratories
• Bayer AG
• Iroko Pharmaceuticals
• LLC
• Scilex Pharmaceuticals Inc.
• Zosano Pharma Corporation
• Adynxx Inc.
• BioElectronics Corporation
• NeuroMetrix Inc.
• Virpax Pharmaceuticals Inc.
• Eli Lilly and Company
• Novartis AG
• Amgen Inc.
• DURECT Corporation
What are the Regional Insights into the Non-Opioid Pain Patch Market?
North America was the largest region in the non-opioid pain patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-opioid pain patch market report during the forecast period. The regions covered in the non-opioid pain patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
